Fund 3

Agate JT Healthcare Fund LP:

Est. 2016, the Agate JT fund was founded as a partnership between Agate and JT Capital (Beijing; Hong Kong) for creating value from the potential of the Israeli advanced technologies in the life science sector, and the mega-sized market capacity and rapid growth of China's health care sector together provide the best context for investment.

The fund wishes to offer solutions to bridge the technological gap in China's healthcare market as the basis for exploring valuable investment opportunities.

The fund believes the industrialization of Israeli advanced technologies in China will be value-adding highlights. Combination of technologies and capital will incentivize market growth and capture value-adding opportunities.

Team:

Dani Naveh- Founder

Agate’s founder brings impressive track record of 30 years in government and the business sector.
 
Mr. Naveh is the founder of Agate's Venture-capital group. Former Israel's Health minister and Member of Parliament. Former Government secretary and head of the negotiations team with the Palestinians.
 
Former key business manager of Israel's largest Health funds (HMO), Chairman of the Board of Directors, CLAL Insurance, one of the top Israeli insurance and long-term savings companies.
 
Mr. Naveh established Agate as one of the leading  healthcare VC funds in Israel with access to the best deal flow and investment opportunities in the market.

Mrs. Batia Tocatly, Founder & Venture Partner

Member of one of the time-honoured families in Israel with more than 70 years insurance track record. Active in the Chinese market since early 1992.
 
A pioneer and lead promoter of Chinese Insurance companies and Reinsurers' activities in the Israeli Insurance market.
 
The Sole Representative of PICC, China Reinsurance (Group) Corporation including China Life Reinsurance Company and China Property & Casualty Reinsurance Company (CPCR) in Israel respectively since 1992.
 
One of the Israeli pioneers to operate successfully in China serving blue chip Chinese clients, such as CITIC, CAS, CASH, Legend Group, Fosun Group, CATIC etc.
 
Latest deal in 2015 – Initiating Fosun Group’s acquisition of Phoenix Insurance – a Israel's leading insurance company – based on company valuation of NIS3.7 B (app.US$1B).
 
Sole representative of Chinese Academy of Sciences Holdings Co., LTD. (CASH) in Israel.

Ariel Moses- Managing Partner

Managing partner, CFO and investment committee member of the Agate Venture capital group, Fund I and Fund II. B.A. economics from the Hebrew University in Jerusalem and L.L.B.
 
Extensive experience in MedTech investments, corporate finance and Fund management. Expert in scouting, analyzing and approving investments. Experience in managing portfolio investments.
 
Board member in MedTech companies: 'MST ‘– Surgery Robotics; 'Tulip‘ –  Obesity control, 'Sensimed‘ a Swiss MEMs company in the Ophthalmic area and ‘AngioSlide’ – angioplasty; ‘Dia Image Analysis’ and Mitos – surgery optronic
 
Former board member in 'Iscare’ European healthcare services company active in IVF, plastic surgery, IBD treatments and general surgery Exited 2017.
 
Former Founder & CEO of a FinTech startup company, developing a multinational ESOP and tax IT system.
 
Vast experience in Corporate Finance as former Analyst in leading Israeli Banking and Insurance corporations, VP Marketing and Analyses in leading asset based corporate finance company.

Mr. Lihu Avitov – Managing Partner

Senior Healthcare Investment Executive, with 18 years of experience.
 
Strategic and entrepreneurial skill set, with in-depth know how in financing, operational and commercial aspects of innovative healthcare companies. Strong background in healthcare Venture Capital.
 
Demonstrated proficiency in planning and executing commercial strategies in US & Asia, investment strategy and portfolio management, fund raising and exit management.
 
Former CEO, AngioSlide Ltd. A privately held MedTech company, developing and commercializing embolic management catheters for vascular interventions.
 
Former EVP, XT investments Ltd. A leading investment firm in technology-based companies, focusing on healthcare and IT ventures, from early-stage to publicly-traded companies

China Team:

Mr. Francis Li Founder & Partner

Mr. Francis Li is JT Capital's Chairman of the Board. Graduated from Peking University with Degree of Law, Francis has over 20 years professional experience in capital investment and is in possession of thorough understanding of multiple industries.
 
Beside acting chairman and the sole shareholder of JT Capital, Mr. Li holds the following positions:
 
Chairman of the Board of Pohua JT Industry Fund
 
Chairman of the Board, Controlling shareholder of Carry Wealth Holdings (0643.HK)
 
Executive Direct, Vice President of BEWG (0371.HK)
 
Executive Vice President of Jinchuan International (2362.HK)
 
Founder and LP of AID Capital
 
Director of Beijing Institute of Technology, Zhuhai.

Mr. Li also holds the following social Titles

Member of 11th PPCC Inner-Mongolia Autonomous Region
 
Deputy Chairman of Centum Charitas Foundation (Hong Kong). Centum Charitas Foundation is a known charity organization in Hong Kong, mainly serves the young generation and low-income groups in Hong Kong.

Mr. Eric Cao Managing Partner

13 years of experience in investing, M&A.
 
Deep understanding and abundant experience in capital market, financial services and fund management.
 
Previously worked in DHL International Logistics Fund as Analyst.
 
Previously worked in Lenovo Holdings and Digital China Financial Service Department, responsible for corporate finance and acquisitions.
 
Previously Executive Direct and Deputy GM of HNA Capital Investment Banking.
 
Currently Managing Director of JT Capital and Pohua JT Industry Fund.
 
Master of Nankai University.

Mr. Weiguo Jin, Venture Partner

Over 20 years of experience in financial services and capital investment.
 
Previously served in Shenzhen Foreign Economic Development Company, PingAn Bank, PICC and Galaxy Securities.
 
Currently works in Poly Longma AMC as Special Advisor to Chairman.
 
Currently Managing Partner of Pohua JT Industry Fund.
 
Experienced Investor in TMT, high-tech and healthcare industries.
 
Graduate of Department of Accounting Finance, the People’s University of China.

Mr. Issac Qin

10 years of experience in capital investment.
 
Previously worked in China Information Technologies (8178.HK) as Director of Investment.
 
Previously worked in Morgan Fund Organization, Canada, as Senior Investment Manager.
 
Previously worked in Colliers International as Manager of Property Investment.
 
Currently worked as Executive Director of Pohua JT, and acting Directors of other 2 listed companies.
 
MSc (honors) in Financial Mathematics of Warwick University, U.K.

Mr. Howard Xu

Many years of service in state-owned utility companies, participated in a series of feasibility studies, investment researches, project financing, project management and construction in ASEAN, Mideast and Africa. Understands the energy industry thoroughly with rich experience.
 
Previously Analyst and Relationship Manager of Bank of New York Mellon, London Branch.
 
Previously worked in BEWG (0371.HK), responsible for investment opportunities in ASEAN Region and setting up of Malaysian subsidiary.
 
Currently works in JT Capital as Executive Director of Pohua JT.

Ms. Maggie Ma

Over 8 years in auditing, 4 years in business management consultancy and 5 years of experience in investing.
 
Previously worked in PWC China, HNA Capital and JT Capital.
 
Provided professional consulting and auditing services to multinational companies, helped a number of the China domestic companies with pre-IPO auditing and asset restructure consultancy.
 
Participated in setting up of logistic fund, structural design of investment, due diligence and post-investment management.
 
Currently works in JT Capital as executive director.

Portfolio

Clew (Formerly: Intensix)

An analytics platform for the prediction of life threatening complications in high acuity care.
 
Using high volume and high velocity analytics, Clew identifies patterns in physiological data that predict a deterioration in the patient’s condition, in real-time. The platform enables physicians to intervene in a timely manner, improving the clinical outcome and reducing the cost of treatment.

https://www.clewmed.com

Innoventric

Tricuspid Regurgitation – TR leads to Increased Venous pressures, impaired liver and kidney function, reduced cardiac output, and, Heart Failure. Ineffective drug treatment for advanced TR, while surgery is hardly performed (1% or TR) and of high mortality risk.

https://www.linkedin.com/in/amir-danino-74800918

Mitos Medical

Proprietary DFV technology, based on electronic, software and optic array, allows the extension of the field of view up to 270 degrees without moving the device and without zoom in/out. A tailor made real time video processing embedded software and camera manipulation will position the MaxScope™ at the frontier of the endoscopy field for many years to come.

http://www.mitosmed.com

Rdd Pharma

Specialty Pharma & Medical Device company focus on lower GI and ano-rectal disorders: Anal Fissure; Fecal Incontinence; Pruritus Ani – and Radiation Proctitis.

http://www.rddpharma.com

V6 (Fofesight Vision 6)

Accommodating Intra Ocular Lens. A flexible IOL structure, using the ciliary muscles activate and control accommodation. The design is based on soft, silicone oil, structure.

Dario Health

DarioHealth Corp. is a leading global digital health company serving its users with dynamic mobile health solutions. In today’s day in age, knowledge of health and treatment is being democratized and we believe people deserve to know everything about their own health, and at the same time have the best tools to manage their treatment.
 
Dario guides people around the world through their daily challenges with diabetes.
 
Dario changed the way people thrive with diabetes, empowering them with the world’s first slick blood-glucose device that automatically syncs with their smartphone to provide 100% data-capturing, real-time insights and personalized actions.
 
Healthcare companies and wellness providers can leverage our engagement platform and AI technology integrating within any clinical program to support their dynamic, personalized care services and innovations.

http://www.dariohealth.com

Contact Us:

Toyota Tower B

67 Yigal Alon St.

Tel-Aviv, Israel

Tel: +972 3 565 2285

agate@agate-invest.com